TaiwanJ Pharmaceuticals Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Rich Yuan
Chief executive officer
NT$3.4m
Total compensation
| CEO salary percentage | 93.0% |
| CEO tenure | 5.9yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | no data |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -NT$6m |
| Sep 30 2023 | n/a | n/a | -NT$38m |
| Jun 30 2023 | n/a | n/a | -NT$71m |
| Mar 31 2023 | n/a | n/a | -NT$82m |
| Dec 31 2022 | NT$3m | NT$3m | -NT$92m |
Compensation vs Market: Rich's total compensation ($USD104.24K) is about average for companies of similar size in the TW market ($USD135.99K).
Compensation vs Earnings: Insufficient data to compare Rich's compensation with company performance.
CEO
Rich Yuan
5.9yrs
Tenure
NT$3,403,000
Compensation
Mr. Hung-Chang Yuan, also known as Rich, has been General Manager of TaiwanJ Pharmaceuticals Co., Ltd. since June 2018 and also serves as its Director. He is Independent Director of Msscorps Co., Ltd.sinc...